Country Meeting:

DAY 1 – Thursday, November 30, 2017

SESSION 1: OPENING AND OBJECTIVES
Chairs: Liudmila Mosina and Brenda Corcoran

• Welcome  
  Simon Harris, MOH Ireland

• Welcome and presentation of the objectives by HPV Prevention and Control Board 
  Alex Vorsters, University of Antwerp, HPV Prevention and Control Board (Belgium)

SESSION 2: THE HEALTH CARE SYSTEMS IN IRELAND AND THE UK
Chairs: Liudmila Mosina & Brenda Corcoran

• The Health Care System in the UK
  Vanessa Saliba, Public Health England (UK)

• Health Care System in Ireland 
  Kevin Kelleher, Health Service Executive (Ireland)

SESSION 3: EPIDEMIOLOGY, BURDEN OF DISEASE AND SURVEILLANCE OF HPV AND HPV RELATED CANCERS IN IRELAND AND THE UK
Chairs: Mario Poljak & Scott Wittet

• HPV associated cancers in Ireland
  Mairead O’Connor, National Cancer Registry Ireland

• Surveillance of HPV; a focus on the UK
  Kate Cuschieri, Royal Infirmary of Edinburgh  (UK)

• Northern Ireland
  Lesley Anderson, Queen’s University Belfast (UK)

SESSION 4: PREVENTION AND CONTROL OF HPV IN IRELAND AND THE UK
Chairs: Mario Poljak and Scott Wittet

• HPV vaccination programme in the UK
  Vanessa Saliba, Public Health England (UK)

• HPV vaccination programme in Ireland 
  Brenda Corcoran, Health Service Executive (Ireland)

SESSION 4: PREVENTION AND CONTROL OF HPV IN IRELAND AND THE UK (Cont’d)
Chairs: Susanne Krûger-Kjaer and Susan Wang

• HPV vaccination in  Northern Ireland: Spill-over of anti-vaccine group messagesfrom Ireland
  Lucy Jessop, Public Health Agency (UK)

• The link between communication and coverage, the case of Ireland
  Paul Connors, Health Service Executive (Ireland)

• Communication and the HPV vaccine. What do parents and teenagers in England think?
  Louise Letley, Public Health England (UK)

• Panel debate : impact of communication on coverage and vice versa
  Moderator: Robert O’Connor
  Panel: Susan Mitchel, Paul Connors, Grainne O’Rourke, Catherine Fegan, David Robert Grimes

SESSION 5: HPV AND HPV RELATED CANCER SCREENING PROGRAMMES IN IRELAND AND THE UK
Chairs: Margaret Stanley & Eduardo Franco

• HPV screening programme and implementation in Ireland 
  Grainne Flannelly/John Gleeson, Cervical Check (Ireland)

• HPV screening programme and implementation in England and Wales
  Ruth Stubbs, Public Health England (UK)

• Self-sampling studies from Scotland
  Grzayna Stanczuk, Western Isles Hospital (UK)

• HPV based screening implementation in Scotland and impact of immunisation
  Tim Palmer, University of Edinburgh (UK)

SESSION 6: KEY NOTE 
Chairs: Rob O’Connor & Bruce Gellin

• The human papilloma virus vaccine; from bench to bedside
  Doug Lowy, National Cancer Institute (US)

DAY 2: Friday, December 1st 2017

SESSION 7: CHALLENGES AND OPPORTUNITIES IN HPV CONTROL
Chairs: Margaret Stanley and Paolo Bonanni

• The HPV crisis in Ireland: a survey among health care provider 
  Poster: ‘The HPV vaccine crisis’ 
  Donal Brennan, Mater Misericordiae University Hospital (Ireland)

• Panel debate on HPV vaccination programmes and the role of health care providers
  Moderator: Pierre Van Damme
  Donal Brennan, Paolo Bonanni, Ros Quinlan

• New developments in anal screening and implications of vaccine in MSM
  Richard Gilson, University College London (UK)

• Gender neutral vaccination. The discussion in the UK and globally
  Mark Jit, London School for Hygiene and Tropical Medicine (UK)

SESSION 8: THE PATIENT’S PERSPECTIVE
Chairs: Mira Kojouharova & Sharon Hanley

• Cervical cancer victim to testify 
  Stefanie Veraghtert, The Big C (Belgium)

SESSION 9: THE WAY FORWARD: BREAK- OUT SESSIONS
Chairs: Alex Vorsters and Kate Cuschieri

Break-out sessions:

• What are important issues to take into account when considering gender neutral vaccination? 
  Chair: Peter Baker

• What should be the research topics to anticipate on future challenges and maintain good coverage? 
  Chair: Doug Lowy

• Lessons learnt from Ireland how to mitigate a crisis. 
  Chair: Liudmila Mosina

• How to articulate and convey “success” of the vaccine program to support future engagement (and to overcome spurious claims)? 
  Chair: Mark Kane

• Presentations from the break-out sessions & discussion

SESSION 10: MEETING CONCLUSIONS
Chairs: Pierre Van Damme and Mark Kane

• Presentation of the meeting conclusions & feedback
  Rob O’Connor & and Brenda Corcoran